Skip to main content

ICYMI: Rivaroxaban reduces VTE incidence in ambulatory cancer patients

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
ICYMI: Rivaroxaban reduces VTE incidence in ambulatory cancer patients

User login

Username

Password

Reset your password

Type	Lead	score